Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Reg 40(9).
Compliance Certificate under Reg 40(9).19-04-2022
19-04-2022
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Dhiraj Rajesh RathiDesignation :- Company Secretary and Compliance Officer11-04-2022
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window30-03-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Akash Farms LLP & Nath Industries Ltd28-03-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 28, 2022 for Agri-Tech (India) Ltd28-03-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Agri-Tech (India) Ltd25-03-2022
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Outcome for Financial Results As On 31St December 2021.
Financial Results as on 31st December 2021.11-02-2022
Nath Bio-Genes (India) Ltd - 537291 - Financial Results As On 31St December 2021
Financial Results as on 31st December 2021.11-02-2022
Nath Bio-Genes (India) Ltd - 537291 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual Fund07-02-2022
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended 31St December 2021.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve financial results for the quarter and nine months ended 31st December 2021.04-02-2022